AstraZeneca

Open: 63.84 Close: 64.27 Change: 0.43

You'll be sorry if you don't use an AI to decide whether to invest in AstraZeneca.

The game is changing. There is a new strategy to evaluate AstraZeneca fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, Astrazeneca, blood, PLC, share, prove, and the …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

Astrazeneca PLC shares rose 2.73% to £100.94 on Friday, on what proved to be an all-around positive trading session. Pfizer confirms Monday that it made a renewed approach to Astrazenec regarding a takeover valued at nearly $100 billion.

Today's News

AstraZeneca PLC shares rose 2.73% to £100.94 on Friday, on what proved to be an all-around positive trading session for the stock market. The company has partnered with the NHL and its players association to promote cancer screening. AstraZeneca PLC ADR closed $12.29 short of its 52-week high ($76.56), which the company achieved on April 25th. Astrazeneca shares closed 2.28% to $64.27 on what proved to be an all-around dismal trading session. Pfizer confirms AstraZeneca approach. Sweden is latest country to stop using astrazeneca vaccine. Pfizer confirmed Monday that it made a renewed approach to Astrazeneca regarding a takeover valued at nearly $100 billion. AstraZeneca announced an industry-first renewable power agreement in China together with four global healthcare leaders and renewable energy company Envision Energy, resulting in potential annual emissions savings of approximately 120,000 tonnes, the equivalent of taking 25,000 cars off the road. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and severe blood condition where red blood cells break down within blood vessels. AstraZeneca has maintained its dominance in the PNH treatment market. AstraZeneca PLCs (AZN) American depositary receipts (ADRs) fell more than 4% Thursday after the drug maker reported its profit was hurt by falling demand for COVID-19 treatments. Deutsche Bank also cut its rating of the stock to Sell from Buy. Astrazeneca and Sanofis respiratory syncytial virus (RSV) immunization for infants has been approved in China. Revenue for Mitiperstat is expected to reach an annual total of $23 mn by 2035 in the US based off GlobalDatas Expiry Model. AstraZeneca has 30 manufacturing and supply sites in 16 countries currently operational or under development. This analyst slightly lowers astrazeneca forecast amid earnings concerns.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, Astrazeneca, blood, PLC, share, prove, and the most common words in the summary are: astrazeneca, stock, market, best, news, credit, price, . One of the sentences in the summary was: Pfizer confirms Monday that it made a renewed approach to Astrazenec regarding a takeover valued at nearly $100 billion.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #stock #market #best #news #credit #price.